ELV vs NPCE · P/E 18, rev $199.13B vs rev $22.8M
Elevance Health Inc (ELV) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Latest reported NPCE revenue for 2026-06-30 was $22.8M. Net income was -$6.2M. Revenue was up 3.4% from 2026-03-31 to 2026-06-30. NPCE currently screens at market cap $312.2M.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the ELV and NPCE stock pages for the full models.
Not investment advice.